FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include pharmaphorum, upi.com, Reuters and Abbott MediaRoom. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 6h ago.
Quick answers
Why is "FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- FDA issues novel nods for diabetes monitor, migraine lenses pharmaphorum · 23h ago
- FDA approves first wearable device to monitor glucose, ketone levels upi.com · 23h ago
- FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients Reuters · 23h ago
- Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes Abbott MediaRoom · 23h ago
- FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones Patient Care Online · 23h ago
Topics
Related trends
FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
World First: Mitochondria From a Woman's Leg Were Injected Into Her Eyes
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
First Look: The Updated Longines Master Collection now gets Light Blue Dials
2 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Instagram’s ‘First Draft’ feature aims to make editing Reels less tedious
10 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Thyroid tablets recalled nationwide over potential ‘superpotency’: FDA
A nationwide recall has been issued for thyroid medication following reports of potential 'superpotency' issues affecting the tablets.
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
The U.S. Department of Health and Human Services plans to expand the FDA's leadership structure with new deputy commissioner roles for technology and drugs.